Brioschi Effervescent Antacid
- Product NDC
- 69276-200
- Requested package NDC
- 69276-200-25
- 11-digit product format
- 692760200
- Labeler code
- 69276
- Product ID
- 69276-200_d25816f8-119b-f188-e053-2a95a90a6008
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sodium bicarbonate
- Dosage form
- GRANULE, EFFERVESCENT
- Route
- ORAL
- Labeler
- Neobourne Pharma LP
- Application
- part331
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2019-09-23
- Marketing end
- 2022-08-31
- Substance
- SODIUM BICARBONATE
- Active strength
- 1 g/5g
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 69276-200 | 69276-200-25 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69276-200-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-14b0-f424-e053-dadaa90a57ce | Brioschi Effervescent Antacid |
| 69276-200-58 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e8af-f424-e053-dadaa90a57ce | Brioschi Effervescent Antacid 300g Bottle |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69276-200-05 | Brioschi Effervescent Antacid | 5 g in 1 PACKET | GRANULE, EFFERVESCENT | 5 | 2 | |
| 69276-200-05 | Brioschi Effervescent Antacid | 10 in 1 CARTON | GRANULE, EFFERVESCENT | 10 | 2 | |
| 69276-200-58 | Brioschi Effervescent Antacid | 300 g in 1 BOTTLE | GRANULE, EFFERVESCENT | 300 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69276-200 | BRIOSCHI EFFERVESCENT ANTACID (SODIUM BICARBONATE) GRANULE, EFFERVESCENT [NEOBOURNE PHARMA LP] | 2 | Legacy NDC, 2 package rows | 20181219_513e0139-2666-07cb-e054-00144ff8d46c.zip |
| 69276-200 | BRIOSCHI EFFERVESCENT ANTACID (SODIUM BICARBONATE) GRANULE, EFFERVESCENT [NEOBOURNE PHARMA LP] | 2 | Legacy NDC, 1 package rows | 20181219_5efce361-3538-6c95-e053-2991aa0aba24.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1656660 | Brioschi 1.02 GM Granule for Oral Solution | PSN | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656660 | Brioschi 1.02 GM Granule for Oral Solution | PSN | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656654 | sodium bicarbonate 1.02 GM per 5 GM Granules for Oral Solution | PSN | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656654 | sodium bicarbonate 1.02 GM per 5 GM Granules for Oral Solution | PSN | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | sodium bicarbonate 1020 MG Granules for Oral Solution [Brioschi Antacid] | SBD | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656660 | sodium bicarbonate 1020 MG Granules for Oral Solution [Brioschi Antacid] | SBD | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656654 | sodium bicarbonate 1020 MG Granules for Oral Solution | SCD | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656654 | sodium bicarbonate 1020 MG Granules for Oral Solution | SCD | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | Brioschi (sodium bicarbonate 1.02 GM per 5 GM) Granules for Oral Solution | SY | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656660 | Brioschi (sodium bicarbonate 1.02 GM per 5 GM) Granules for Oral Solution | SY | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | Brioschi (sodium bicarbonate 1020 MG) Granules for Oral Solution | SY | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656660 | Brioschi (sodium bicarbonate 1020 MG) Granules for Oral Solution | SY | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | Brioschi Antacid 1020 MG Granules for Oral Solution | SY | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | Brioschi Antacid 1020 MG Granules for Oral Solution | SY | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656654 | NaHCO3 1020 MG Granules for Oral Solution | SY | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
| 1656654 | NaHCO3 1020 MG Granules for Oral Solution | SY | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | NaHCO3 1020 MG Granules for Oral Solution [Brioschi Antacid] | SY | 5efce361-3538-6c95-e053-2991aa0aba24 | 2 |
| 1656660 | NaHCO3 1020 MG Granules for Oral Solution [Brioschi Antacid] | SY | 513e0139-2666-07cb-e054-00144ff8d46c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69276-200-25 | 69276020025 | 240 g in 1 BOTTLE (69276-200-25) | 240 g | 2019-09-23 | 2023-03-31 | No | No | Current |